Table 4 The frequency of abnormal components in subjects with dyslipidemia between 2007 and 2013.
Male | Female | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
2007 | 2013 | 2007 | 2013 | |||||||
Crude | ASR | Crude | ASR | P value | Crude | ASR | Crude | ASR | P value | |
TC | 17.80% | 17.12% | 18.94% | 15.98% | <0.01* | 16.74% | 14.84% | 23.38% | 18.91% | <0.01* |
TG | 33.86% | 33.49% | 44.35% | 43.49% | <0.01* | 26.66% | 24.73% | 47.29% | 41.77% | <0.01* |
LDL-C | 28.50% | 26.76% | 18.11% | 15.47% | <0.01* | 27.49% | 24.57% | 20.21% | 16.48% | <0.01* |
HDL-C | 15.30% | 15.58% | 32.72% | 34.96% | <0.01* | 7.62% | 7.71% | 22.32% | 22.96% | <0.01* |